Range Low Price High Price Comment
30 days $36.92 $43.67 Monday, 29th Apr 2024 RYTM stock ended at $38.82. This is 1.41% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 3.08% from a day low at $38.19 to a day high of $39.37.
90 days $36.92 $52.55
52 weeks $15.50 $52.55

Historical Rhythm Pharmaceuticals Inc prices

Date Open High Low Close Volume
Apr 29, 2024 $38.60 $39.37 $38.19 $38.82 280 278
Apr 26, 2024 $38.39 $38.89 $37.40 $38.28 296 523
Apr 25, 2024 $38.77 $38.77 $37.36 $38.15 422 125
Apr 24, 2024 $40.57 $40.92 $39.56 $39.71 379 356
Apr 23, 2024 $39.39 $41.79 $39.19 $40.00 413 648
Apr 22, 2024 $38.31 $39.42 $37.76 $39.01 361 220
Apr 19, 2024 $37.79 $39.02 $36.92 $38.01 596 814
Apr 18, 2024 $37.83 $38.90 $37.62 $38.11 428 184
Apr 17, 2024 $39.10 $39.10 $38.25 $38.45 566 411
Apr 16, 2024 $39.59 $40.11 $38.51 $38.52 413 208
Apr 15, 2024 $40.46 $41.04 $39.96 $40.09 552 692
Apr 12, 2024 $42.01 $42.01 $39.81 $40.33 831 349
Apr 11, 2024 $41.23 $42.63 $41.12 $42.58 341 920
Apr 10, 2024 $41.93 $42.59 $40.97 $41.10 529 479
Apr 09, 2024 $41.99 $43.67 $40.79 $43.61 377 599
Apr 08, 2024 $40.81 $41.92 $40.48 $41.80 339 127
Apr 05, 2024 $39.60 $41.36 $39.25 $40.54 460 397
Apr 04, 2024 $41.51 $42.20 $39.86 $40.10 426 382
Apr 03, 2024 $39.70 $40.96 $39.43 $40.89 447 109
Apr 02, 2024 $41.76 $42.07 $39.85 $40.05 599 923
Apr 01, 2024 $42.30 $42.77 $41.57 $42.68 565 983
Mar 28, 2024 $42.50 $43.66 $41.79 $43.33 808 432
Mar 27, 2024 $40.20 $42.40 $39.57 $41.79 628 385
Mar 26, 2024 $39.95 $41.06 $39.17 $39.53 390 894
Mar 25, 2024 $40.40 $41.01 $39.35 $39.65 428 606
Click to get the best stock tips daily for free!

About Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström s... RYTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT